127 related articles for article (PubMed ID: 2946233)
1. Absence of normal keratan sulfate in the blood of patients with macular corneal dystrophy.
Thonar EJ; Meyer RF; Dennis RF; Lenz ME; Maldonado B; Hassell JR; Hewitt AT; Stark WJ; Stock EL; Kuettner KE
Am J Ophthalmol; 1986 Nov; 102(5):561-9. PubMed ID: 2946233
[TBL] [Abstract][Full Text] [Related]
2. Macular corneal dystrophy. Lack of keratan sulfate in serum and cornea.
Klintworth GK; Meyer R; Dennis R; Hewitt AT; Stock EL; Lenz ME; Hassell JR; Stark WJ; Kuettner KE; Thonar EJ
Ophthalmic Paediatr Genet; 1986 Dec; 7(3):139-43. PubMed ID: 2951638
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in macular corneal dystrophy.
Edward DP; Yue BY; Sugar J; Thonar EJ; SunderRaj N; Stock EL; Tso MO
Arch Ophthalmol; 1988 Nov; 106(11):1579-83. PubMed ID: 3056354
[TBL] [Abstract][Full Text] [Related]
4. Quantification of keratan sulfate in blood as a marker of cartilage catabolism.
Thonar EJ; Lenz ME; Klintworth GK; Caterson B; Pachman LM; Glickman P; Katz R; Huff J; Kuettner KE
Arthritis Rheum; 1985 Dec; 28(12):1367-76. PubMed ID: 2935158
[TBL] [Abstract][Full Text] [Related]
5. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype.
Klintworth GK; Oshima E; al-Rajhi A; al-Saif A; Thonar EJ; Karcioglu ZA
Am J Ophthalmol; 1997 Jul; 124(1):9-18. PubMed ID: 9222226
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evidence of heterogeneity in macular corneal dystrophy.
Yang CJ; SundarRaj N; Thonar EJ; Klintworth GK
Am J Ophthalmol; 1988 Jul; 106(1):65-71. PubMed ID: 3293458
[TBL] [Abstract][Full Text] [Related]
7. Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures.
Klintworth GK; Smith CF
Am J Pathol; 1977 Oct; 89(1):167-82. PubMed ID: 143892
[TBL] [Abstract][Full Text] [Related]
8. Measurement of activities of human serum sulfotransferases which transfer sulfate to the galactose residues of keratan sulfate and to the nonreducing end N-acetylglucosamine residues of N-acetyllactosamine trisaccharide: comparison between normal controls and patients with macular corneal dystrophy.
Hasegawa N; Torii T; Nagaoka I; Nakayasu K; Miyajima H; Habuchi O
J Biochem; 1999 Feb; 125(2):245-52. PubMed ID: 9990120
[TBL] [Abstract][Full Text] [Related]
9. Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases.
Funderburgh JL; Funderburgh ML; Rodrigues MM; Krachmer JH; Conrad GW
Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):419-28. PubMed ID: 2138589
[TBL] [Abstract][Full Text] [Related]
10. Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy.
Plaas AH; West LA; Thonar EJ; Karcioglu ZA; Smith CJ; Klintworth GK; Hascall VC
J Biol Chem; 2001 Oct; 276(43):39788-96. PubMed ID: 11514545
[TBL] [Abstract][Full Text] [Related]
11. Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing.
Quantock AJ; Meek KM; Ridgway AE; Bron AJ; Thonar EJ
Curr Eye Res; 1990 Apr; 9(4):393-8. PubMed ID: 2340750
[TBL] [Abstract][Full Text] [Related]
12. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan.
Hassell JR; Newsome DA; Krachmer JH; Rodrigues MM
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3705-9. PubMed ID: 6447876
[TBL] [Abstract][Full Text] [Related]
13. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism.
Edward DP; Thonar EJ; Srinivasan M; Yue BJ; Tso MO
Ophthalmology; 1990 Sep; 97(9):1194-200. PubMed ID: 2234853
[TBL] [Abstract][Full Text] [Related]
14. Serum sulfotransferase levels in patients with macular corneal dystrophy type I.
Hassell JR; Klintworth GK
Arch Ophthalmol; 1997 Nov; 115(11):1419-21. PubMed ID: 9366673
[TBL] [Abstract][Full Text] [Related]
15. Abnormal product of corneal explants from patients with macular corneal dystrophy.
Klintworth GK; Smith CF
Am J Pathol; 1980 Oct; 101(1):143-58. PubMed ID: 6969547
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotype classification of macular corneal dystrophy: first case report of immunophenotype I A outside of Saudi Arabia. A clinical histopathological correlation with immunohistochemistry and electron microscopy].
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Küchle M
Klin Monbl Augenheilkd; 2000 Aug; 217(2):118-26. PubMed ID: 11022667
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to proteokeratan sulfate of rabbit corneal stroma.
SundarRaj N; Willson J; Gregory JD; Damle SP
Curr Eye Res; 1985 Jan; 4(1):49-54. PubMed ID: 2579771
[TBL] [Abstract][Full Text] [Related]
18. Structural collagen alterations in macular corneal dystrophy occur mainly in the posterior stroma.
Palka BP; Sotozono C; Tanioka H; Akama TO; Yagi N; Boote C; Young RD; Meek KM; Kinoshita S; Quantock AJ
Curr Eye Res; 2010 Jul; 35(7):580-6. PubMed ID: 20597644
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody.
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Haubeck HD; Küchle M; Naumann GO
Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360
[TBL] [Abstract][Full Text] [Related]
20. Novel CHST6 nonsense and missense mutations responsible for macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Shalaby O; Wilkins S; Poopalasundaram S; Cheetham M; Tuft SJ; Hardcastle AJ; Bhattacharya SS; Ebenezer ND
Am J Ophthalmol; 2005 Jan; 139(1):192-3. PubMed ID: 15652851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
